Organon & Co. is a global health care company. Co. is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and established brands. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Co.'s Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, respiratory, dermatology and non-opioid pain management. We show 17 historical shares outstanding datapoints in our OGN shares outstanding history coverage, used to compute OGN market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing OGN market cap history over the course of time is important for investors
interested in comparing OGN's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of OGN versus a peer is one thing; comparing
OGN market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like OGN can fluctuate over the course of history.
With this page we aim to empower investors researching OGN by allowing them to research the OGN market cap history. |
Free OGN Email Alerts:
Video: The Importance of Market Cap
